ReviewJournal of travel medicine2026
Time requirements of pre-acclimatization at simulated altitude to prevent acute mountain sickness.
Review in Journal of travel medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Biomarkers and potential subtypes of acute mountain sickness: A state-of-the-science review.Redox biology · 2026Review
- Combining exercise and hypoxia for brain health: from elite athlete altitude training camps to clinical applications.AIMS neuroscience · 2026Review
- Pre-ascent hypoxic preparedness for rapid-ascent mountain sports: translating military evidence into civilian acclimatization research.Frontiers in physiology · 2026Article
- What Is Possible for Patients After Lung Transplantation? The Highest Reported Altitude Achieved by a Lung Transplant Recipient Without Supplemental Oxygen - Climbing Mount Aconcagua (6.961m).Transplant international : official journal of the European Society for Organ Transplantation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTravelling to high altitudes (sleeping above 2500 m) carries a risk of acute mountain sickness (AMS). Proper pre-acclimatization strategies, such as time spent at simulated altitude, can significantly lower this risk. However, the optimal duration of pre-acclimatization remains unknown. Therefore, we examined published research on how different types and durations of pre-acclimatization at simulated altitude influence the AMS risk.
methodsA literature search was conducted to find controlled studies investigating the effects of normobaric or hypobaric simulated altitude exposures. Inclusion criteria required sufficient details on study design, exposure duration and outcomes, specifically the incidence of AMS on subsequent ascent. The simulated or real altitude exposure following pre-acclimatization had to last at least eight hours to accurately assess AMS incidence.
resultsFindings from seven controlled studies using repeated intermittent exposures to simulated altitude were included. The cumulative pre-acclimatization time ranged from 7 to 104 hours; altitudes ranged from 2200 to 5000 m. The AMS risk after pre-acclimatization decreased by 12-73% compared to controls, with the degree of reduction depending mainly on the duration at simulated altitude. Extrapolating from these data indicates that, within the analysed altitude range, ~200 hours of pre-acclimatization may reduce the subsequent AMS risk to nearly zero.
conclusionsOur analysis suggests that accumulating 200 hours in a hypoxic simulated-altitude environment substantially reduces the risk of AMS when subsequently exposed to terrestrial altitude. The effectiveness of this strategy depends on the intervals between pre-acclimatization exposures, the method used and the target altitude. Observational studies indicate that time spent at simulated altitude can be complemented by time spent at terrestrial altitude. Importantly, while pre-acclimatization exposures can effectively prevent AMS, they do not, per se, enhance endurance performance or mountaineering skills, and factors such as co-existing mental or physical health conditions may influence risk and the effectiveness of prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.